Access Vascular

About Access Vascular

Access Vascular is a company focused on transforming vascular access by offering a suite of devices made with a novel hydrophilic biomaterial featuring MIMIX technology. Their mission is to solve the greatest challenges in vascular access by reducing complications, improving patient experience, and potentially saving significant costs for healthcare facilities.

Products & Services

HydroPICC:A vascular access PICC catheter made with MIMIX technology, designed to reduce complications compared to standard polyurethane catheters.

Specialties

Vascular Access Devices Hydrophilic Biomaterials MIMIX Technology Reduction in Catheter Complications

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 22000000 MR: - FA: $22 million FAN: 22000000	D: 2023-10-31 FD: 2023-10-31	-

Series C Latest

2023-10-31

$22.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

JAMES BIGGINS

Chief Executive Officer, President and Founder

D

DENNIS BYRNE

Chief Commercial Officer

S

SCOTT BLOOD

VP of Regulatory and Quality

K

KATIE MOTHERWAY

VP of Human Resources

A

AARON DYNES

Controller

D

Dr Michael R. Jaff

Founder of VasCore and VP at Boston Scientific

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Access Vascular Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised